MTB
63
2
TRV
56
-2
GE
71
6
SYY
52
2
AMT
39
-4
LYB
41
-2
REGN
49
4
LRCX
61
3
COP
48
-2
CPB
32
-3
AMGN
26
3
LUV
52
3
MUR
47
-2
FMC
51
-3
CI
60
-5
VFC
54
4
HPQ
52
-3
NOV
49
-4
GME
52
-2
AEP
67
-3
MTB
63
2
TRV
56
-2
GE
71
6
SYY
52
2
AMT
39
-4
LYB
41
-2
REGN
49
4
LRCX
61
3
COP
48
-2
CPB
32
-3
AMGN
26
3
LUV
52
3
MUR
47
-2
FMC
51
-3
CI
60
-5
VFC
54
4
HPQ
52
-3
NOV
49
-4
GME
52
-2
AEP
67
-3
Financhill
Back

Windtree Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
13

WINT
Windtree Therapeutics

Last Price:
$0.10
Seasonality Move:
-5.58%
Sell
33

CATX
Perspective Therapeutics

Last Price:
$3.6200
Seasonality Move:
-20.76%
Sell
13
Windtree Therapeutics (WINT) is a Sell

Is Windtree Therapeutics a Buy, Sell or Hold?

  • The current Windtree Therapeutics [WINT] share price is $0.10. The Score for WINT is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
  • WINT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.6000. The Score for CATX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WINT Stock Price Chart

What is Windtree Therapeutics's stock price today?

  • The Windtree Therapeutics share price today is $0.10
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.6000
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.

WINT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.16 Sell
Relative Strength Index (14 RSI): 23.02 Sell
Chaikin Money Flow: -574294 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.28 - 0.82) Sell
Bollinger Bands (100): (0.5 - 1.08) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 47.2 Sell
Chaikin Money Flow: 140780 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.56 - 4.02) Sell
Bollinger Bands (100): (2.3657 - 3.8857) Buy

WINT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.26 Sell
20-day SMA: 0.45 Sell
50-day SMA: 0.63 Sell
200-day SMA: 6.5 Sell
8-day EMA: 0.23 Sell
20-day EMA: 0.42 Sell
50-day EMA: 0.7 Sell
200-day EMA: 83.74 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.55 Buy
20-day SMA: 3.71 Sell
50-day SMA: 3.79 Sell
200-day SMA: 3.47 Buy
8-day EMA: 3.59 Buy
20-day EMA: 3.69 Sell
50-day EMA: 3.63 Sell
200-day EMA: 4.49 Sell

Windtree Therapeutics Earnings Growth & WINT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $313.50 per share, and a decrease next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.17 per share.

Windtree Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):